• br Discussion Variant angina was described by Prinzmetal et

  2019-05-10

  

  Discussion Variant VER155008 Supplier was described by Prinzmetal et al. in 1959 [1]. It can involve serious arrhythmias such as ventricular tachycardia, ventricular fibrillation, and atrioventricular block, and patients are particularly susceptible to sudden cardiac death in such cases [2,3]. Co

• In an early meta analysis diagnosing cancer of the pancreas

  2019-05-10

  

  In an early meta-analysis, diagnosing cancer of the pancreas by ERCP with the “double duct” sign had a sensitivity of 92% and specificity of 96%. In the present case, mild proximal CBD dilatation with an abrupt distal CBD stricture was detected by ERCP. The most common malignant cause of obstructive

• Because our patient s native rhythm

  2019-05-09

  

  Because our patient׳s native rhythm remained 2:1 AV block with a narrow QRS, we attempted HBP as the first-line treatment based on the assumption that His-Purkinje conduction might be preserved. Another benefit of HBP in this patient with CKD is that the use of iodinated ion channel media could be

• Limitations of meta analyses are often based on the strength

  2019-05-09

  

  Limitations of meta-analyses are often based on the strength of the data available. Only 26% of the eligible studies were judged to be at low risk of overall bias in this analysis. Other studies may have been at low risk for bias but failed to report information necessary for this determination. All

• br Purpose br Methods Participating centers Forty main ICSD

  2019-05-09

  

  Purpose Methods Participating centers: Forty main ICSD centers in Japan from Hokkaido to Okinawa, which cover approximately 20% of all new ICSD patients in Japan, are participating in the present study. After obtaining written informed consent, all patients (over 20 years old) will be register

• br Discussion Clinically HES may be separated

  2019-05-09

  

  Discussion Clinically, HES may be separated into two subgroups: HES with, and HES without gene abnormality such as PDGFRA, PDGFRB, or FGFR1. The standard therapy of HES without gene abnormality is steroid; by contrast, the first-line therapy of HES with gene abnormality is imatinib. Although in-

• RG2833 br Conclusion and future directions br Conflict of in

  2019-05-09

  

  Conclusion and future directions Conflict of interest Acknowledgments Introduction Epithelial-mesenchymal transition (EMT) is a process by which epithelial RG2833 lose their polarity and are converted to a mesenchymal phenotype; recently, this has been regarded as the critical event that

• Twenty six of the patients had an early

  2019-05-09

  

  Twenty-six of the 98 patients had an early discontinuation due to recurrence: there were 14 patients with distant no donors and 12 with local recurrence. Most distant metastatic events (71.4%) occurred within the initial two years. Of the other 72 patients with early discontinuation of ET, only sev

• Several anti platelet therapies have been evaluated

  2019-05-09

  

  Several anti-platelet therapies have been evaluated in the context of bone metastasis. In vitro, a dual anti-platelet treatment using the soluble ADPase APT102 and an inhibitor of TxA2 synthesis (Aspirin) markedly affected tumor cell-induced platelet aggregation without altering tumor cell viability

• br Ocular surface squamous neoplasia OSSN

  2019-05-08

  

  Ocular surface squamous neoplasia (OSSN) has emerged as an important manifestation of the HIV epidemic, especially in sub-Saharan Africa. This region has not only gained the unenviable position of having the highest prevalence of OSSN, but patients with HIV tend to present with larger tumours and

• Cardiac troponin I cTnI is a well established sensitive

  2019-05-08

  

  Cardiac troponin I (cTnI) is a well-established, sensitive, and specific marker of myocardial injury. However, evidence indicates that unrecognized myocardial injury may be occurring with certain conditions such as sepsis without acute coronary ischemic event, which demonstrate elevated cTnI levels.

• br Conclusion Our findings may help physicians in selecting

  2019-05-08

  

  Conclusion Our findings may help physicians in selecting high-priority patients for bisphosphonate treatment. Zoledronic MLN4924 is indicated for treating patients with MBD from any malignancy [1,35]; however, many patients do not receive treatment (especially in NSCLC and CRPC). Although it may

• Well designed operational research is needed to refine this

  2019-05-08

  

  Well designed operational research is needed to refine this starting point. Research is also needed to find out whether prophylactic valganciclovir treatment in high-risk patients might reduce AIDS mortality as well as blindness, as substantial data suggest. WHO leadership is needed to provide cytom

• La expansi n exportadora de Argentina hacia

  2019-05-08

  

  La expansión exportadora de Argentina hacia Colombia, Perú y Venezuela respondió Etonogestrel distintas razones, pero los mercados obviamente tuvieron mucho que ver. No fue casual que Colombia, por ejemplo, concentrara más de 65% de sus importaciones de Argentina en bienes primarios, pues la agricul

• br Discussion Chronic myelogenous leukemia CML

  2019-05-08

  

  Discussion Chronic myelogenous leukemia (CML) is a clonal disorder involving the pluripotent stem cell and is consistently associated with the BCR-ABL1 fusion gene located on the Philadelphia chromosome [1]. The disease typically evolves in 3 distinct clinical stages: chronic and accelerated phas

15998 records 1056/1067 page Previous Next First page 上5页 10561057105810591060 下5页 Last page